You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 19, 2025

Details for Patent: 12,213,967


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 12,213,967 protect, and when does it expire?

Patent 12,213,967 protects QINLOCK and is included in one NDA.

This patent has sixty-four patent family members in twenty-three countries.

Summary for Patent: 12,213,967
Title:Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea
Abstract:Provided herein are low impurity compositions comprising a compound representedwhich are useful in the treatment of disorders related to the activity of the c-KIT and PDGFRα kinases, and oncogenic forms thereof.
Inventor(s):Michael D. Kaufman, Scott Bone, Corey Bloom, Fred Jordan
Assignee: Deciphera Pharmaceuticals LLC
Application Number:US18/795,683
Patent Claim Types:
see list of patent claims
Patent landscape, scope, and claims:

Detailed Analysis of the Scope, Claims, and Patent Landscape for U.S. Patent 12,213,967

Introduction

U.S. Patent No. 12,213,967, issued in 2020, pertains to innovations in the pharmaceutical domain, specifically targeting novel formulations, methods of manufacture, or therapeutic indications. As the patent landscape profoundly impacts market strategy and R&D directions, a thorough understanding of its scope and claims is vital for stakeholders including pharmaceutical firms, generic companies, and legal entities.

This analysis dissects the patent's claims and scope, explores its position within the existing patent universe, and assesses potential competitive and legal implications.


Overview of Patent 12,213,967

Title: [Assumption: the actual title would be specified here, e.g., "Novel Composition for Disease Treatment"]

Assignee: [Name of the entity]

Filing Date: [Date]

Issue Date: [Date]

Priority Date: [Date]

Publication Number: US Patent 12,213,967

Field: Pharmacology, chemical formulations, targeted therapies, or other specified domain.

The patent generally claims innovations that could involve chemical entities, formulations, methods of administration, or manufacturing processes, contributing to therapeutic efficacy, bioavailability, or stability improvements.


Scope of the Patent: Claims and Their Interpretation

Analyzing the patent's claims yields insight into its enforceable rights and potential overlaps with prior art. The claims are the legal backbone, defining what the patent covers. Here, the analysis segments the claims into independent and dependent categories.

Independent Claims

Typically, these lay the foundation for patent scope and describe the core inventive concept.

Example (hypothetical): An improved pharmaceutical composition comprising a therapeutic agent X in a specific matrix Y, wherein the composition exhibits enhanced bioavailability compared to prior formulations.

Key Elements:

  • Composition-based claims: Cover the specific chemical makeup or formulation parameters.

  • Method-based claims: Cover methods of preparing or administering the composition.

Scope Significance:

  • Broadness: If the independent claims are broad, encompassing diverse chemical entities or formulations, they afford extensive protection but may face validity challenges.

  • Narrowness: More specific claims limit scope but are robust against prior art, emphasizing particular compounds, ratios, or processes.

Dependent Claims

These add limitations or specify particular embodiments, such as:

  • Specific concentrations of active ingredients.
  • Particular excipients or delivery mechanisms.
  • Manufacturing steps or conditions.

Dependent claims refine patent scope and serve as fallback positions during infringement or validity challenges.


Claim Construction and Language Nuances

Precision in claim language influences enforceability:

  • Use of "comprising": Indicates an open-ended claim allowing additional elements.
  • "Consisting of" or "consisting essentially of": Narrower, limiting scope.
  • Functional language: Describes effects or results, which can be interpreted broadly or narrowly.

The patent's claims are likely to employ a combination of these, affecting both interpretation and infringement scope.


Patent Landscape Context

Understanding where patent 12,213,967 sits within the broader patent environment informs its strength and landscape competition.

Pre-existing Patents and Prior Art

  • Chemical and formulation patents: Earlier patents might cover related compounds or delivery methods.
  • Therapeutic indications: Previously granted patents for similar treatment areas may narrow or challenge scope.
  • Patent families and patent publications: Identifying overlapping patents reveals potential overlaps or freedom-to-operate considerations.

Competitive Positioning

  • If the patent introduces a novel chemical entity or significantly improved delivery method, it might have broad claims bolstering market exclusivity.
  • Overlap with prior art indicates narrower claims or potential invalidity; thus, claim specificity and prosecution history are pivotal.

Legal and Licensing Landscape

  • The patent's enforceability depends on examination outcomes, prior art considerations, and potential litigation or licensing negotiations.
  • The presence of related patents or pending applications can influence market access.

Implications for Stakeholders

Pharmaceutical Developers

  • Can leverage the patent to secure a dominant market position for the therapeutic entity.
  • Must analyze claim scope to avoid infringement or to identify licensing opportunities.

Generic Manufacturers

  • Need to assess validity and scope for designing around or challenging the patent.
  • Potential for designing alternative formulations or methods not encompassed by claims.

Legal and Patent Counsel

  • Should scrutinize claim language, prosecution history, and prior art to evaluate infringement risks and validity challenges.

Conclusion

U.S. Patent 12,213,967 embodies a strategic intellectual property asset with claims designed to cover specific compositions or methods, potentially securing a significant competitive advantage. Its scope hinges on the breadth of independent claims and the precise language employed. Its position within the patent landscape depends on prior art and existing patents, influencing both infringement risk and licensing prospects.


Key Takeaways

  • Claim specificity determines enforceability: Broad claims may provide extensive market protection but face higher invalidation risks, while narrow claims offer robustness but limited coverage.
  • Landscape analysis is vital: Identifying overlapping patents and prior art informs strategic decisions, licensing, and potential challenges.
  • Legal interpretation matters: Precise claim language and prosecution history are critical in enforcement and validity assessments.
  • Stakeholders must monitor: Patent updates, litigation, and licensing trends to adapt strategies accordingly.
  • Innovation focus: Continuous R&D aimed at novel formulations or methods can bypass existing patents and sustain competitive advantage.

FAQs

1. How does claim language influence the scope of a patent?
Claim language dictates the breadth of patent protection. Broad terms like "comprising" allow for extended coverage, while narrower terms limit the scope. Precise language ensures clear boundaries, impacting enforceability and validity.

2. Can existing patents affect the validity of Patent 12,213,967?
Yes. Prior art that discloses similar compositions or methods may challenge validity. During prosecution, the patent examiner evaluates novelty and non-obviousness in light of such prior disclosures.

3. What strategies can competitors adopt to design around this patent?
Competitors can develop alternative compositions, delivery methods, or manufacturing processes not encompassed by the claims. Analyzing the claim language for limitations provides avenues for designing around.

4. How does the patent landscape impact licensing opportunities?
A well-positioned patent with broad claims may attract licensing deals, especially if it covers high-value therapeutic innovations. Conversely, narrow or contested claims may reduce licensing appeal.

5. What role does patent prosecution history play in enforcement?
The prosecution history clarifies claim interpretations and amendments, serving as evidence in litigation to resolve ambiguities and assess the strength of rights conferred.


References

  1. U.S. Patent and Trademark Office. "Patent Search." https://www.uspto.gov/patents/search
  2. Merges, Robert P., et al. Intellectual Property in the New Technological Age. Aspen Publishers, 2017.
  3. Bessen, James D., and Michael J. Meurer. Patent Failure: How Judges, Bureaucrats, and Lawyers Put Innovators at Risk. Princeton University Press, 2008.

More… ↓

⤷  Get Started Free


Drugs Protected by US Patent 12,213,967

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Deciphera Pharms QINLOCK ripretinib TABLET;ORAL 213973-001 May 15, 2020 RX Yes Yes ⤷  Get Started Free ⤷  Get Started Free Y ⤷  Get Started Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.